OraSure Technologies Cash on Hand 2010-2025 | OSUR
OraSure Technologies cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| OraSure Technologies Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $268 |
| 2023 | $290 |
| 2022 | $111 |
| 2021 | $153 |
| 2020 | $209 |
| 2019 | $156 |
| 2018 | $157 |
| 2017 | $156 |
| 2016 | $121 |
| 2015 | $101 |
| 2014 | $98 |
| 2013 | $93 |
| 2012 | $88 |
| 2011 | $24 |
| 2010 | $76 |
| 2009 | $80 |
| OraSure Technologies Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $248 |
| 2024-12-31 | $268 |
| 2024-09-30 | $279 |
| 2024-06-30 | $267 |
| 2024-03-31 | $264 |
| 2023-12-31 | $290 |
| 2023-09-30 | $225 |
| 2023-06-30 | $186 |
| 2023-03-31 | $112 |
| 2022-12-31 | $111 |
| 2022-09-30 | $102 |
| 2022-06-30 | $96 |
| 2022-03-31 | $112 |
| 2021-12-31 | $153 |
| 2021-09-30 | $185 |
| 2021-06-30 | $193 |
| 2021-03-31 | $207 |
| 2020-12-31 | $209 |
| 2020-09-30 | $236 |
| 2020-06-30 | $257 |
| 2020-03-31 | $166 |
| 2019-12-31 | $156 |
| 2019-09-30 | $164 |
| 2019-06-30 | $147 |
| 2019-03-31 | $147 |
| 2018-12-31 | $157 |
| 2018-09-30 | $150 |
| 2018-06-30 | $145 |
| 2018-03-31 | $144 |
| 2017-12-31 | $156 |
| 2017-09-30 | $162 |
| 2017-06-30 | $162 |
| 2017-03-31 | $141 |
| 2016-12-31 | $121 |
| 2016-09-30 | $121 |
| 2016-06-30 | $113 |
| 2016-03-31 | $102 |
| 2015-12-31 | $101 |
| 2015-09-30 | $108 |
| 2015-06-30 | $91 |
| 2015-03-31 | $89 |
| 2014-12-31 | $98 |
| 2014-09-30 | $99 |
| 2014-06-30 | $80 |
| 2014-03-31 | $84 |
| 2013-12-31 | $93 |
| 2013-09-30 | $83 |
| 2013-06-30 | $77 |
| 2013-03-31 | $79 |
| 2012-12-31 | $88 |
| 2012-09-30 | $89 |
| 2012-06-30 | $23 |
| 2012-03-31 | $23 |
| 2011-12-31 | $24 |
| 2011-09-30 | $21 |
| 2011-06-30 | $75 |
| 2011-03-31 | $72 |
| 2010-12-31 | $76 |
| 2010-09-30 | $74 |
| 2010-06-30 | $75 |
| 2010-03-31 | $73 |
| 2009-12-31 | $80 |
| 2009-09-30 | $83 |
| 2009-06-30 | $79 |
| 2009-03-31 | $79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.203B | $0.186B |
| OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $225.007B | 26.38 |
| Boston Scientific (BSX) | United States | $154.324B | 36.80 |
| Stryker (SYK) | United States | $144.711B | 29.46 |
| EssilorLuxottica (ESLOY) | France | $142.399B | 0.00 |
| Medtronic (MDT) | Ireland | $117.900B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.114B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.571B | 24.87 |
| ResMed (RMD) | United States | $41.687B | 29.81 |
| Agilent Technologies (A) | United States | $33.767B | 22.01 |
| GE HealthCare Technologies (GEHC) | United States | $33.630B | 15.81 |
| Terumo (TRUMY) | Japan | $27.538B | 32.63 |
| Koninklijke Philips (PHG) | Netherlands | $26.220B | 17.34 |
| Insulet (PODD) | United States | $22.229B | 74.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.230B | 12.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.039B | 0.00 |
| Baxter (BAX) | United States | $12.558B | 9.70 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.773B | 28.55 |
| Lantheus Holdings (LNTH) | United States | $3.704B | 10.01 |
| Envista Holdings (NVST) | United States | $3.460B | 24.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.179B | 14.10 |
| Perrigo (PRGO) | Ireland | $3.169B | 7.91 |
| ICU Medical (ICUI) | United States | $2.762B | 18.81 |
| Haemonetics (HAE) | United States | $2.521B | 11.25 |
| LeMaitre Vascular (LMAT) | United States | $2.169B | 46.51 |
| Curaleaf Holdings (CURLF) | Canada | $1.969B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.827B | 78.46 |
| QuidelOrtho (QDEL) | United States | $1.762B | 11.09 |
| AtriCure (ATRC) | United States | $1.760B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.299B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.284B | 18.25 |
| Phibro Animal Health (PAHC) | United States | $1.239B | 15.84 |
| BioLife Solutions (BLFS) | United States | $1.213B | 2532.00 |
| Neogen (NEOG) | United States | $1.195B | 18.97 |
| Acuren (TIC) | United States | $1.153B | 0.00 |
| InMode (INMD) | Israel | $0.903B | 8.35 |
| Valneva SE (VALN) | France | $0.891B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.820B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| SNDL (SNDL) | Canada | $0.554B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.543B | 0.00 |
| Surmodics (SRDX) | United States | $0.538B | 0.00 |
| ZimVie (ZIMV) | United States | $0.531B | 20.47 |
| Cresco Labs (CRLBF) | United States | $0.489B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.447B | 15.40 |
| CeriBell (CBLL) | United States | $0.432B | 0.00 |
| Owens & Minor (OMI) | United States | $0.417B | 3.70 |
| Evolus (EOLS) | United States | $0.414B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.357B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.356B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.324B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.271B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Omeros (OMER) | United States | $0.254B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.251B | 0.00 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 49.35 |
| Vireo Growth (VREOF) | United States | $0.240B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.209B | 0.00 |
| High Tide (HITI) | Canada | $0.207B | 0.00 |
| Exagen (XGN) | United States | $0.206B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 15.21 |
| FitLife Brands (FTLF) | United States | $0.152B | 18.67 |
| Biote (BTMD) | United States | $0.147B | 4.89 |
| TriSalus Life Sciences (TLSI) | United States | $0.147B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.102B | 0.00 |
| Jin Medical (ZJYL) | China | $0.099B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.14 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.080B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 35.37 |
| Agape ATP (ATPC) | $0.061B | 0.00 | |
| Veru (VERU) | United States | $0.054B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 33.33 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.034B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |